Published: Nov-2022|  Format: PDF | MBI Research |  Number of pages: 140 | Code: MBI-3929936

Cancer Immunotherapy Market Size, Share, Growth & Demand Analysis Report By Type (Checkpoint Inhibitors, Cancer Vaccines, Immunomodulators, Monoclonal Antibodies) By Application (Prostate Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer, Breast Cancer, Melanoma, and Others) Forecast Period 2022-2030

Select a Format




 Buy Now

Market Overview:

The Global Cancer Immunotherapy Market size was valued at USD 83.8 billion in 2021 and is projected to register a valuation of USD 275.5 billion by 2030, at a Compound Annual Growth Rate CAGR of 13.9% over the forecast period 2022-2030.

Growing acceptance of therapies targeted over traditional methods, the introduction of biosimilars, and the rising prevalence of chronic diseases like cancer are some of the major factors contributing to the growth of the market. Research and development activities in the field of cancer immunotherapy have increased in number, resulting in the emergence of new forms that enhance the effectiveness and efficacy of treatments.

Immunotherapy is a new treatment for cancer. It has a unique mechanism of action by which it affects the body's own immune system to fight cancer. Conceptually chemotherapy and targeted therapy target cancer cells. Chemotherapy kills rapidly dividing cells, especially cancer cells. Targeted therapy is designed to target cancer cells with specific molecular abnormalities. In contrast, immunotherapy guides your immune cells to recognize and kill cancer cells. Immunotherapy is thus completely different from chemotherapy or targeted therapy.

Immunotherapy is usually given as an injection through an intravenous drip. Checkpoint inhibitors and CAR T cells have revolutionized the field of immuno-oncology. Checkpoint inhibitors are used in advanced solid malignancies while CAR T cells are used in some hematological malignancies.

Covid-19 Impact Analysis:

The outbreak of COVID-19 and the subsequent extent of the lockdown have impacted the cancer immunotherapy market across the globe. As the Covid-19 crisis continues, many global industrial manufacturing companies are facing challenging times including production shutdowns, transportation, supply chain disruptions, cost increases, and workforce disruptions, which have several negative impacts on the global cancer immunotherapy market industry in terms of revenue.

Clinical trials of new cancer immunotherapy drugs have been put on hold, as a person is more susceptible to COVID-19 during this crisis. However, Covid-friendly cancer treatments are seen to increase over time and will continue to increase in the near future.

Driving Factors:

Moreover, the side effects of chemotherapy have prompted patients to opt for other treatment options, leading to an increase in the demand for immunotherapy, which has aided the growth of the cancer immunotherapy market. In addition, immunotherapy can be used to treat many types of cancer such as breast cancer, skin cancer, lung cancer, etc.

Some of the factors driving the market growth include increasing R&D activities, increasing the effectiveness and accuracy of new therapies, adoption therapies targeting conventional medicine, and increasing the prevalence of cancer. The increasing incidence of cancer is a major factor driving the growth of the cancer immunotherapy market. According to the National Clinical Trials Registry, there were more than 1,000 ongoing clinical trials globally in various stages of development for treating cancer with immune-based therapies.

Restraining Factor:

The global cancer immunotherapy market is a high accident rate present in the product development cycle, to be more specific about abstinence, depending on the type of cancer and type of patients, cancer cannot be treated just once. Accordingly, the accident rate in the development of new drugs and treatments is very high are some of the factors restraining the growth of the market.

Key Market Players:

  • F. Hoffmann-La Roche (Switzerland)
  • Celgene Corporation (US)
  • Bristol-Myers Squibb (US)
  • Merck & Co., Inc. (US)
  • Amgen Inc. (US)
  • ELI Lilly and Company (US)
  • Janssen Global Services, LLC (US)
  • Novartis (Switzerland)
  • Pfizer, Inc. (US)
  • Gilead Sciences, Inc. (US)
  • Dendreon Pharmaceuticals (US)
  • Bayer (Germany)

Market Segmentation:

The global cancer immunotherapy market is segmented by type, by application, and region.

By Type

On the basis of type the market is segmented into, Checkpoint Inhibitors, Cancer Vaccines, Immunomodulators, and Monoclonal Antibodies.

The monoclonal antibody segment had the major market share in 2021. Monoclonal antibodies are the most commonly prescribed immunotherapeutic drugs in the world.

By Application

On the basis of application the market is segmented into, Prostate Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer, Breast Cancer, Melanoma, and Others.

The breast cancer segment is anticipated to be the fastest-growing segment during the forecast period. This can be attributed to the rapidly increasing cases of breast cancer in the global female population.

Regional Analysis:

The global cancer immunotherapy market is categorized into regions such as Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.

The North American region is expected to lead the global market as the region is witnessing an increase in the prevalence of chronic diseases such as cancer, and increased access to advanced treatments with a growing aging population.

On the other hand, The Asia Pacific region is projected to grow at a rapid rate over the forecast period and this is due to an increase in FDA approvals for novel drugs and therapies and an increase in the number of clinical trials to introduce new drugs to countries. India and China, which are experiencing an aging population growth, are likely to increase the patient pool.

Report Coverage: 

Market Segmentation:

By Type

  • Checkpoint Inhibitors
  • Cancer Vaccines
  • Immunomodulators
  • Monoclonal Antibodies

By Application

  • Prostate Cancer
  • Colorectal Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Breast Cancer
  • Melanoma
  • Others

By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global Cancer Immunotherapy Market to Grow at a (CAGR) of 13.9% during the Forecast Period 2022-2030

18-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Cancer Immunotherapy Market is projected to reach USD 275.5 billion by 2030. Moreover, increasing day-by-day incidence of cancer, increasing awareness about early diagnosis, the effectiveness of thera ...

Global In-Vehicle Infotainment Market to Grow at a (CAGR) of 9.8% during the Forecast Period 2022-2030

17-Nov-2022 | Automobile

As specified in our exclusive report, the global  In-Vehicle Infotainment Market is projected to reach USD 42.25 billion by 2030. In-vehicle infotainment systems provide entertainment and information services to the driver and passengers throughou ...

Global Blockchain in Healthcare Market to Grow at a (CAGR) of 59% during the Forecast Period 2022-2030

16-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global Blockchain in Healthcare Market is projected to reach USD 119 billion by 2030. The growing need for curbing these issues along with the increasing incidence of information leaks and data breaches has be ...

Global In Vitro Fertilization Market to Grow at a (CAGR) of 5.7% during the Forecast Period 2022-2030

14-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global In-Vitro Fertilization Market is projected to reach USD 32 billion by 2030. In-vitro fertilization involves some risks such as genetic disease transfer during the pr ...

Global Microfluidics Market to Grow at a (CAGR) of 15.8% during the Forecast Period 2022-2030

11-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Microfluidics Market is projected to reach USD 61 billion by 2030. The growth in demand for point-of-care (POC) devices is expected to majorly drive the market size in the coming years. Simultaneously demand ...

More News...